Mirum Pharmaceuticals, Inc.
MIRM
$96.55
$3.914.22%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -297.25% | 149.56% | 60.07% | 38.31% | -67.12% |
| Total Depreciation and Amortization | 0.20% | 0.10% | 0.07% | -0.07% | 0.02% |
| Total Amortization of Deferred Charges | -1.58% | 3.75% | -1.39% | 4.09% | -1.89% |
| Total Other Non-Cash Items | 6.44% | 0.85% | 2.54% | 25.81% | 7.40% |
| Change in Net Operating Assets | -215.33% | 285.25% | 41.97% | -571.64% | -36.53% |
| Cash from Operations | -84.71% | 229.58% | 713.97% | 61.31% | -227.21% |
| Capital Expenditure | -220.86% | -48.41% | -207.32% | -105.00% | 88.95% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 178.73% | 68.48% | 59.78% | -2,534.64% | 103.70% |
| Cash from Investing | 145.17% | 66.25% | 59.10% | -2,617.00% | 103.55% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -44.09% | 85.27% | 36.63% | 19.08% | 38.23% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -44.09% | 85.27% | 36.63% | 19.08% | 38.23% |
| Foreign Exchange rate Adjustments | -216.91% | -84.32% | 111.00% | 176.50% | -1,667.05% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -70.94% | 229.56% | 253.12% | -2,192.06% | 95.39% |